Orofacial Development of Preterm and Low Birthweight Infants Versus Term Infants
NCT ID: NCT00408746
Last Updated: 2009-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
80 participants
OBSERVATIONAL
2003-01-31
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oral Feeding Delay Prevention in Preterm Newborns
NCT06184386
Effects of Prefeeding Oral Stimulation on Feeding Performance in Preterm Infants
NCT01649362
A Comparison Study of Feeding Prematures in the Side-lying Position on the Right and Left Side - a Pilot Study.
NCT04987983
Effects of Oral Stimulation in Preterm Infants
NCT03911674
Acquisition of Full Oral Feeding and Further Oral Disorders in Extremely Preterm Infants
NCT06648083
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of the present study, therefore is to investigate in consideration of perinatal, biometrical, nutritional, functional and parental parameters
* whether preterm babies without a history of orotracheal intubation and orogastric feeding do have an altered orofacial development as compared to term babies.
* in a second step whether preterm babies with a history of orotracheal intubation and orogastric feeding do have an altered orofacial development as compared to preterm and term infants without these interventions.
The participants must meet the following inclusion criteria:
all:
* caucasian origin and
* informed consent by both parents. term infants:
* born at ≥ 37 weeks of gestation
* birthweight ≥ 2500 g.
preterm infants (will be allocated in two groups depending on the absence or presence of a history of orotracheal intubation and orogastric feeding):
* gestational age at birth \> 25 weeks and
* birthweight \> 500 g.
Exclusion criteria are hydrocephalus, oral or facial clefts, congenital syndrome, deformity of the head and neck and congenital metabolic disease beyond osteopenia of prematurity.
The children will be examined at the following times:
* 2-5 days prior to discharge from hospital (weight \> 1800 g in the preterm group)
* 40 weeks of gestation ( + 7 days tolerance)
* 3, 6, 9, 12, 15 and 18 months of corrected age (+ 28 days tolerance)
* 24, 36, 48 and 60 months of corrected age (+ 28 days tolerance).
The following measures will be taken at all times:
child:
* standardized questionnaire for evaluation of biometrical (weight, length/height, head circumference), nutritional and functional parameters (breast/bottle/spoon feeding, mode of breathing, lip and tongue posture, sucking habits, kind of pacifiers and suckers)
* standardized frontal and lateral photographs
* alginate impressions of the upper jaw
* measurement of the overjet.
child and parents: - smear of the oral mucosa.
The following measures will be taken once (at time of discharge from hospital):
child:
* standardized questionnaire concerning perinatal parameters. parents:
* standardized questionnaire concerning parents orofacial history
* standardized frontal and lateral photographs
* alginate impressions of the both jaws and wax bite
* measurement of the overjet
* dental and periodontal findings.
The following measures will be taken at the investigation times during the time the child is breast or bottle fed (measures stopped at the latest when the child has a corrected age of twelve months:
child:
* sucking of the child at an alginate filled condom
* ultrasound of the feeding process.
The following measures will be taken at a corrected age of 36 and 50 months:
child:
\- alginate impression of the lower jaw, wax bite.
As a positive side effect the database -beyond the primary aim of the study- will be useful in evaluating the influence of hereditary, perinatal, functional and nutritional parameters on orofacial development in general, it will serve as control data for therapies in patients with craniofacial defects (e.g. clefts) and provide a basis for development of physiologic pacifying, feeding and intensive care devices.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
palatal development
Impressions of preterm and term palates.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* delivery between May 1999 and December 2008
* caucasian origin
* written informed consent by both parents
Exclusion Criteria
* hydrocephalus
* palatal cleft, congenital syndrome, head / neck malformation
* congenital metabolic disease beyond osteopenia of prematurity
5 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NUK Baby Care, Mapa GmbH, Industriestrasse 21-25, 27404 Zeven
UNKNOWN
TOP-Service für Lingualtechnik GmbH, Lindenstr. 42, 49152 Bad Essen
UNKNOWN
University Hospital Muenster
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University Hospital Muenster
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ariane Hohoff, PD Dr.
Role: PRINCIPAL_INVESTIGATOR
Universitätsklinikum Münster, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitätsklinikum Münster
Münster, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Hohoff A, Rabe H, Ehmer U, Harms E. Palatal development of preterm and low birthweight infants compared to term infants - What do we know? Part 1: The palate of the term newborn. Head Face Med. 2005 Oct 28;1:8. doi: 10.1186/1746-160X-1-8.
Hohoff A, Rabe H, Ehmer U, Harms E. Palatal development of preterm and low birthweight infants compared to term infants - What do we know? Part 2: The palate of the preterm/low birthweight infant. Head Face Med. 2005 Oct 28;1:9. doi: 10.1186/1746-160X-1-9.
Hohoff A, Rabe H, Ehmer U, Harms E. Palatal development of preterm and low birthweight infants compared to term infants -- What do we know? Part 3: discussion and conclusion. Head Face Med. 2005 Nov 2;1:10. doi: 10.1186/1746-160X-1-10.
Hohoff A, Stamm T, Meyer U, Wiechmann D, Ehmer U. Objective growth monitoring of the maxilla in full term infants. Arch Oral Biol. 2006 Mar;51(3):222-35. doi: 10.1016/j.archoralbio.2005.07.007. Epub 2005 Aug 31.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KFO-MAPA-1/2006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.